Publications database

In March 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]tetrahydrofuran- 2-carboxamide, commonly known as tetrahydrofuranylfentanyl (THF-F), through a joint assessment. The two organisations launched a...

In March 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}- 3,3-dimethylbutanoate, commonly known as 5F-MDMB-PINACA, through a joint assessment. The two organisations launched a...

In March 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)- 1H-indazole-3-carboxamide, commonly known as AB-CHMINACA, through a joint assessment. The two organisations launched a data...

In March 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl) isobutyramide, commonly known as 4-fluoroisobutyrylfentanyl (4F-iBF), through a joint assessment. The two organisations launched a...

In this issue: Lisbon Addictions 2017 | New EMCDDA guide on responses | EMCDDA responds to increasing risks posed by new fentanils | IPA5 project draws to a close | Supporting global...

This report presents the key activities performed by the EMCDDA and Europol in 2016 and the results of the implementation of Council Decision 2005/387/JHA on the information exchange, risk assessment and control...

In November 2016, the EMCDDA and Europol examined the available information on a new psychoactive substance N -phenyl- N -[1-(2-phenylethyl)piperidin-4-yl]-furan-2-carboxamide, commonly known as furanylfentanyl, through a joint assessment. Furanylfentanyl is a synthetic...

The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses. Together with...

This report provides a first look at the emergence of more problematic forms of use of new psychoactive substances among a range of demographic groups, including opioid and amphetamine injectors, prisoners, the...

Synthetic cannabinoids represent the largest group of substances currently monitored in Europe by the EMCCDA through the EU Early Warning System. Current knowledge on these substances and trends in production, availability, use...